You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,517,560


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,517,560 protect, and when does it expire?

Patent 11,517,560 protects RHOFADE and is included in one NDA.

This patent has seven patent family members in seven countries.

Summary for Patent: 11,517,560
Title:Stabilized oxymetazoline formulations and their uses
Abstract:The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial erythema associated with rosacea in a patient in need of such treatment, comprising topically administering once or twice daily to the site of erythema on the face of the patient a pharmaceutical composition comprising 0.5%, 1.0% or 1.5% oxymetazoline or a pharmaceutically acceptable salt thereof as the sole active ingredient.
Inventor(s):Sarpotdar Pramod, Warner Kevin, Zhang Steven, Ahluwalia Gurpreet, Kuang Amy
Assignee:EPI HEALTH, LLC
Application Number:US16924782
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,517,560

Introduction

United States Patent 11,517,560, titled "Stabilized oxymetazoline formulations and their uses," is a significant patent in the pharmaceutical industry, particularly in the field of dermatology. This patent, issued to its inventors and assignees, protects innovative formulations and methods related to oxymetazoline, a common ingredient in over-the-counter medications.

Patent Structure and Components

Front Page and Bibliographic Data

The front page of the patent document contains crucial bibliographic data identified by INID codes. These codes include:

  • Document Number: Indicated by the prefix "US" and the code "B2," signifying a U.S. patent with a previously published application[1].
  • Application Number: The unique identifier for the patent application.
  • Date of Application: The date when the patent application was filed.
  • Date of Patent: The date when the patent was granted.
  • IPC Classification: International Patent Classification codes that categorize the invention.
  • National Classification: Specific U.S. classification codes, such as those related to pharmaceutical formulations.
  • Title of the Invention: A brief description limited to 500 characters or less.
  • References: Prior art cited by the inventor and patent examiner[1].

Abstract

The abstract provides a non-technical description of the invention, giving a general overview of what the patent covers[1].

Drawings

While not always required, the drawings section illustrates the technical details of the invention. For formulations, this might include diagrams of the manufacturing process or the structure of the formulation[1].

Specification

This section is a detailed written description of the invention, including discussions of prior art, descriptions of the drawings, how the invention solves a specific technical problem, and the preferred embodiment of the invention. It must be detailed enough for anyone with ordinary skill in the same technical field to understand and replicate the invention[1].

Claims

The claims section is critical as it defines the scope of protection for the patent. Here are some key points:

Definition of Claims

Claims are paragraphs at the end of the specification that outline the legal boundaries of the invention. They must start with phrases like “I claim” or “What is claimed” and are numbered[1].

Types of Claims

  • Independent Claims: These define the broadest scope of the invention.
  • Dependent Claims: These narrow down the scope by adding additional limitations to the independent claims.

Example of a Claim

For a patent like 11,517,560, a claim might read:

  • "A stabilized cream formulation comprising oxymetazoline, a stabilizing agent, and a carrier, wherein the stabilizing agent prevents degradation of oxymetazoline."

Scope of Protection

Independent Claims

The independent claims in Patent 11,517,560 would define the broadest scope of protection, such as the composition of the stabilized oxymetazoline formulation and its method of use. These claims are crucial as they set the boundaries of what is protected under the patent.

Dependent Claims

Dependent claims would further specify the formulation, such as the concentration of oxymetazoline, the type of stabilizing agent used, or specific methods of application. These claims provide additional protection by covering various aspects of the invention that are not as broad as the independent claims.

Patent Landscape

Prior Art

The patent landscape includes prior art cited by the inventor and the patent examiner. This section helps in understanding what existing technologies or formulations were considered during the examination process. For oxymetazoline formulations, prior art might include other stabilizing methods or different application methods[1].

Related Patents

Other patents related to oxymetazoline or similar formulations can provide insight into the competitive landscape. Tools like the Patent Public Search, Global Dossier, and Common Citation Document (CCD) can help in identifying these related patents and understanding how they intersect with Patent 11,517,560[4].

International Context

Given the global nature of pharmaceuticals, it is important to look at international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) to see if similar patents have been filed or granted in other countries[4].

Economic and Market Impact

Market Domination

A patent like 11,517,560 can give its holders significant market advantage by protecting their unique formulations and methods. This can lead to market domination in the treatment of conditions like rosacea, where oxymetazoline is commonly used.

Licensing and Collaboration

The patent can also be a valuable asset for licensing agreements or collaborations with other pharmaceutical companies. This can expand the reach of the formulation and generate revenue through royalties.

Legal and Regulatory Considerations

Term Adjustment

The term of the patent can be adjusted due to processing delays, which can add additional days to the patent's term. For example, a term adjustment of 11 days might be applied to compensate for delays in the examination process[1].

Office Actions

The Patent Examination Data System (PEDS) and Global Dossier can provide insights into office actions and the examination history of the patent, which can be crucial for understanding the legal strength and potential challenges to the patent[4].

Practical Applications and Uses

Treatment of Rosacea

The stabilized oxymetazoline formulations covered by this patent are specifically designed for treating rosacea and its symptoms. The unique stabilizing agents and methods of application can enhance the efficacy and stability of the formulation, making it a preferred treatment option.

Manufacturing and Distribution

The patent details the preferred embodiment of the invention, including how to manufacture the formulation. This information is vital for companies looking to produce and distribute the product.

Key Takeaways

  • Patent Structure: The patent includes bibliographic data, abstract, drawings, specification, and claims.
  • Claims: Define the scope of protection and are divided into independent and dependent claims.
  • Scope of Protection: Covers the composition and method of use of the stabilized oxymetazoline formulation.
  • Patent Landscape: Includes prior art, related patents, and international context.
  • Market Impact: Can lead to market domination and generate revenue through licensing.
  • Legal Considerations: Includes term adjustments and office actions.

FAQs

Q: What is the main subject of United States Patent 11,517,560? A: The main subject is stabilized oxymetazoline formulations and their uses, particularly in treating rosacea.

Q: How do claims define the scope of protection in a patent? A: Claims define the legal boundaries of the invention, with independent claims setting the broadest scope and dependent claims narrowing it down.

Q: What tools can be used to search for related patents? A: Tools like the Patent Public Search, Global Dossier, and Common Citation Document (CCD) can be used to search for related patents.

Q: How can a patent like 11,517,560 impact the market? A: It can give the holders significant market advantage, lead to market domination, and generate revenue through licensing agreements.

Q: What is the significance of the drawings section in a patent document? A: The drawings section illustrates the technical details of the invention, which can include diagrams of the manufacturing process or the structure of the formulation.

Sources

  1. Guides.library.queensu.ca: How to Read a U.S. Patent - Patents and Designs - Research Guides.
  2. Wiki.golden.com: US Patent 11517560 Stabilized oxymetazoline formulations and their uses.
  3. USPTO.gov: Patent Claims Research Dataset.
  4. USPTO.gov: Search for patents - USPTO.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,517,560

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mayne Pharma RHOFADE oxymetazoline hydrochloride CREAM;TOPICAL 208552-001 Jan 18, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ONCE DAILY TOPICAL TREATMENT OF PERSISTENT FACIAL ERYTHEMA ASSOCIATED WITH ROSACEA IN FEMALE ADULTS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,517,560

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015274532 ⤷  Subscribe
Canada 2951725 ⤷  Subscribe
European Patent Office 3154517 ⤷  Subscribe
Spain 2796871 ⤷  Subscribe
Mexico 2016016400 ⤷  Subscribe
New Zealand 727233 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.